IRCT20120605009948N7已完成3 期
Difficult weaning of mechanical ventilation due to hypothyroidism
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients without previously known thyroid disease
- •Mechanical ventilation more than one week
排除标准
- •Brain and lung diseases
- •History of interfering drugs with thyroid consumption such as Lithium
- •Patient dissatisfaction
- •History of heart diseases
- •Arrhythmia without cause
- •Patients with history of Hypothyroidism
研究者
相似试验
尚未招募
1 期
ess invasive surfactant administration vs Intubation, surfactant and extubation in preterm neonates with respiratory distress syndromeCTRI/2021/04/032720Dr Ashu Jamwal
终止
不适用
Weaning From Mechanical Ventilation Using Permissive HypercarbiaRespiration, ArtificialRespiratory Distress Syndrome, AdultNCT00357929Milton S. Hershey Medical Center3
已完成
2 期
Evaluation of the impact of nursing educational on outcomes among hospitalized neonates under mechanical ventilatioCondition 1: Broncoho pulmonary dysplasia. Condition 2: Ventilator Associated Pneumonia. Condition 3: Pulmonary hemorrhage. Condition 4: Pneumothorax.lung diseasesDiseases of the respiratory systemPulmonary hemorrhageIRCT2013101615040N1Vice Chancellor for Research, Tehran University of Medical Sciences120
已完成
不适用
Assessment of weaning from mechanical ventilation in mechanically ventilated patients at Thammasat University Hospitalprotocol of weaning from mechanical ventilationfactors affecting delayed weaning and weaning failureclinical outcomes relating to weaning from invasive mechanical ventilation.weaningdelayedfailuremechanical ventilation.TCTR20180306001Faculty of Medicine, Thammasat University32
已完成
不适用
Decreased time on mechanical ventilation when comparing analgesia-based sedation using remifentanil versus standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial.Medical or surgical patients requiring intensive care.SurgeryISRCTN47583497GlaxoSmithKline